Mylotarg and disseminated intravascular coagulation 
Mylotarg and disseminated intravascular coagulation Patient Reports February 12, 2012
Mylotarg Side Effects Report #5138681-X
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 20, 2006. Female patient, 34 years of age, weighting 163.1 lb, was diagnosed with acute promyelocytic leukaemia, leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute promyelocytic leukaemia, aspergillosis, bacteria stool identified, bronchopulmonary aspergillosis, cerebrovascular accident, cytomegalovirus infection
, diastolic dysfunction, disseminated intravascular coagulation, electrocardiogram qt prolonged. Mylotarg dosage: unknown. During the same period patient was treated with ARSENIC PENTOXIDE, ACYCLOVIR, SEPTRA DS, AVELOX, PROTONIX, LASIX, CELEXA. Patient was hospitalized. Patient died on 01/15/2003.Mylotarg Side Effects Report #5158527-3
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Nov 07, 2006. Female patient, 73 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blood creatinine increased, blood urea increased, condition aggravated, disease progression, disseminated intravascular coagulation, febrile neutropenia, hyperuricaemia, hypokalaemia, white blood cell count decreased. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY. During the same period patient was treated with LIVALO, ENALAPRIL MALEATE, ADALAT OR, METHYCOBAL, ASPARA K, MUCOSOLVAN, LEVOFLOXACIN. Patient recovered.
Mylotarg Side Effects Report #5196079-2
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Dec 07, 2006. Female patient, 72 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood albumin decreased, blood bilirubin increased, disseminated intravascular coagulation, lymphocyte percentage decreased, lymphocyte percentage increased, neutrophil percentage decreased. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY INTRAVENOUS DRIP. During the same period patient was treated with FAMOTIDINE, ASPARA K, ITRACONAZOLE, SULFAMETHOXAZOLE, BIOFERMIN. Patient died.
Mylotarg Side Effects Report #5217521-4
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Jan 11, 2007. Male patient, 71 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: abdominal pain upper, c-reactive protein increased, disseminated intravascular coagulation, febrile neutropenia, haematocrit decreased, haemoglobin decreased, peptic ulcer
, white blood cell count decreased. Mylotarg dosage: 6 MG/M^2 1X PER DAY INTRAVENOUS DRIP. During the same period patient was treated with ZANTAC, MUCOSTA, DIFLUCAN, POLYMYXIN B SULPHATE, CLARITHROMYCIN, SULFAMETHOXAZOLE. Patient was hospitalized. Patient recovered.Mylotarg Side Effects Report #5110505-6
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Sept 04, 2006. Male patient, 68 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, disseminated intravascular coagulation, fatigue, febrile neutropenia, hypotension, malignant neoplasm progression, pneumonia
, pyrexia, thrombocytopenia. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY INTRAVENOUS DRIP; SEE IMAGE. During the same period patient was treated with ITRACONAZOLE, SULFAMETHOXAZOLE, NEORAL, TENORMIN. Patient was hospitalized. Patient recovered.Mylotarg Side Effects Report #4844624-6
Mylotarg side effect was reported by a Health Professional from JAPAN on Nov 16, 2005. Male patient, 68 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: apnoea, blast cell count increased, blood pressure increased, disease progression, disseminated intravascular coagulation, dizziness
, febrile neutropenia, glucose urine present, hepatic failure. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY, INTRAVENOUS DRIP. During the same period patient was treated with DAUNORUBICIN HYDROCHLORIDE, INSULIN, BASEN, BUFFERIN, RABEPRAZOLE, DAONIL, EVIPROSTAT, GLUCOBAY. Patient died.Mylotarg Side Effects Report #4917040-6
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Feb 02, 2006. Male patient, 68 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blast cell count increased, blood pressure increased, disease progression, disseminated intravascular coagulation, dizziness
, febrile neutropenia, hepatic failure, hyperhidrosis, infusion related reaction. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY INTRAVENOUS DRIP. During the same period patient was treated with DAUNORUBICIN HYDROCHLORIDE, INSULIN, BASEN, BUFFERIN, RABEPRAZOLE, GLYBURIDE, EVIPROSTAT, GLUCOBAY. Patient died.Mylotarg Side Effects Report #4988124-1
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Apr 14, 2006. Male patient, 68 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: aspiration pleural cavity, blood pressure increased, disseminated intravascular coagulation, febrile neutropenia, glucose urine present, hepatic failure, hyperhidrosis, infusion related reaction, pleural effusion. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY INTRAVENOUS DRIP. During the same period patient was treated with DAUNORUBICIN HYDROCHLORIDE, INSULIN, BASEN, BUFFERIN, RABEPRAZOLE, GLYBURIDE, EVIPROSTAT, GLUCOBAY. Patient died.
Mylotarg Side Effects Report #4998582-4
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Apr 28, 2006. Male patient, 68 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: disseminated intravascular coagulation, fatigue, febrile neutropenia, hypotension, pyrexia, thrombocytopenia. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY INTRAVENOUS DRIP. During the same period patient was treated with ITRACONAZOLE, SULFAMETHOXAZOLE, NEORAL, TENORMIN. Patient recovered.
Mylotarg Side Effects Report #5086082-5
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Aug 04, 2006. Male patient, 66 years of age, was diagnosed with acute myeloid leukaemia recurrent, sinusitis
and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anaemia, aspartate aminotransferase increased, blast cell count increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, c-reactive protein increased, chills, disseminated intravascular coagulation, gamma-glutamyltransferase increased. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY INTRAVENOUS DRIP. During the same period patient was treated with CARBENIN, LEVOFLOXACIN, VANCOMYCIN HYDROCHLORIDE, VFEND, ZANTAC, MUCOSTA, URSO. Patient was hospitalized. Patient recovered.Mylotarg Side Effects Report #5043092-1
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on June 15, 2006. Male patient, 66 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, bilirubin conjugated increased, blood bilirubin increased, blood lactate dehydrogenase increased, disseminated intravascular coagulation, hepatic function abnormal, infection
, interstitial lung disease. Mylotarg dosage: 9 MG/M^2 1 PER 1 DAY INTRAVENOUS DRIP. During the same period patient was treated with POLYMYXIN B SULPHATE, RABEPRAZOLE, NEUTROGIN. Patient died.Mylotarg Side Effects Report #5046899-X
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on June 20, 2006. Male patient, 66 years of age, was diagnosed with acute myeloid leukaemia recurrent, sinusitis
and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anaemia, aspartate aminotransferase increased, blast cell count increased, blood lactate dehydrogenase increased, c-reactive protein increased, chills, disseminated intravascular coagulation, gamma-glutamyltransferase increased, glucose urine present. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY INTRAVENOUS DRIP. During the same period patient was treated with CARBENIN, LEVOFLOXACIN, VANCOMYCIN HYDROCHLORIDE, VFEND, ZANTAC, MUCOSTA, URSO. Patient was hospitalized. Patient recovered.Mylotarg Side Effects Report #5076380-3
Mylotarg side effect was reported by a Health Professional from JAPAN on July 25, 2006. Male patient, 64 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, bone marrow failure, cancer pain, cardiac failure congestive, constipation
, disseminated intravascular coagulation, febrile neutropenia, histiocytosis haematophagic, hypertension. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY INTRAVENOUS DRIP. During the same period patient was treated with NEUQUINON, METHYCOBAL, SUCRALFATE, LANSOPRAZOLE. Patient was hospitalized. Patient died.Mylotarg Side Effects Report #4972939-X
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Mar 29, 2006. Male patient, 57 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: c-reactive protein increased, condition aggravated, disseminated intravascular coagulation, epistaxis, gastrointestinal haemorrhage, hyperchloraemia, hypernatraemia, hypokalaemia, malignant neoplasm progression. Mylotarg dosage: A SINGLE 9 MG/M^2 DOSE INTRAVENOUS DRIP. During the same period patient was treated with DIFLUCAN, RABEPRAZOLE, BEZATOL, EVAMYL, CARBENIN. Patient recovered.
Mylotarg Side Effects Report #5104160-9
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Aug 29, 2006. Male patient, 56 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anaemia, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, blood pressure decreased, body temperature decreased, disseminated intravascular coagulation, gamma-glutamyltransferase increased. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY INTRAVENOUS DRIP; 9 MG/M^2 1X PER 1 DAY INTRAVENOUS DRIP. During the same period patient was treated with OMEPRAZOLE, MAXIPIME, AMIKACIN SULPHATE, MEROPENEM, TIENAM, CIPROXAN. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #4911952-5
Mylotarg side effect was reported by a Health Professional from JAPAN on Jan 31, 2006. Female patient, 54 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blood pressure decreased, disseminated intravascular coagulation, renal failure. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY INTRAVENOUS DRIP. During the same period patient was treated with MAXIPIME, MINOCYCLINE HYDROCHLORIDE, FUTHAN. Patient recovered.
Mylotarg Side Effects Report #5035407-5
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on June 09, 2006. Female patient, 54 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blood pressure decreased, disease progression, disseminated intravascular coagulation, renal failure. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY. During the same period patient was treated with MAXIPIME, MINOCYCLINE HYDROCHLORIDE, FUTHAN. Patient recovered.
Mylotarg Side Effects Report #5151889-2
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Oct 31, 2006. Male patient, 51 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, anaemia, bilirubin conjugated increased, blood alkaline phosphatase increased, blood bilirubin increased, blood lactate dehydrogenase increased, cellulitis
, disseminated intravascular coagulation, dysphagia. Mylotarg dosage: 6 MG/M^2 1X PER 1 DAY INTRAVENOUS DRIP; SEE IMAGE. During the same period patient was treated with CYTARABINE, NOVANTRONE, POLYMYXIN B SULPHATE, FAMOTIDINE, SULFAMETHOXAZOLE, ALLORINE, VFEND. Patient was hospitalized. Patient died.Mylotarg Side Effects Report #5217067-3
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Jan 09, 2007. Male patient, 46 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anaemia, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, disseminated intravascular coagulation, febrile neutropenia, herpes simplex
, infusion related reaction. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY. During the same period patient was treated with CYTARABINE, FRAGMIN, KYTRIL, NORVASC. Patient was hospitalized. Patient recovered.Mylotarg Side Effects Report #5220629-0
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Jan 18, 2007. Male patient, 46 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anaemia, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, c-reactive protein increased, disseminated intravascular coagulation, febrile neutropenia, herpes simplex
. Mylotarg dosage: unknown. During the same period patient was treated with CYTARABINE, FRAGMIN, KYTRIL, NORVASC. Patient was hospitalized. Patient recovered.Mylotarg Side Effects Report #4839607-6
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Nov 10, 2005. Female patient, 44 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, chills, disseminated intravascular coagulation, febrile neutropenia, fibrin degradation products increased, gamma-glutamyltransferase increased. Mylotarg dosage: A SINGLE 9 MG/M^2 DOSE, INTRAVENOUS DRIP. During the same period patient was treated with LAMIVUDINE, COTRIM, DIFLUCAN, CIPROFLOXACIN HYDROCHLORIDE, ZOLPIDEM TARTRATE, MAXIPIME. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #4867132-5
Mylotarg side effect was reported by a Physician from JAPAN on Dec 13, 2005. Female patient, 44 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, bone marrow failure, c-reactive protein increased, disseminated intravascular coagulation, febrile neutropenia, fibrin degradation products increased. Mylotarg dosage: A SINGLE 9 MG/M^2 DOSE INTRAVENOUS DRIP. During the same period patient was treated with LAMIVUDINE, COTRIM, DIFLUCAN, CIPROFLOXACIN HYDROCHLORIDE, ZOLPIDEM TARTRATE, MAXIPIME. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #5224065-2
Mylotarg side effect was reported by a Physician from JAPAN on Jan 18, 2007. Male patient, weighting 149.9 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis, sedation and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, anaemia, cellulitis
, disseminated intravascular coagulation, dysphagia, hepatic function abnormal, herpes simplex , hypoalbuminaemia, mouth haemorrhage. Mylotarg dosage: unknown. During the same period patient was treated with NOVANTRONE, POLYMYXIN B SULPHATE, FAMOTIDINE, BACTRIM, MIDAZOLAM, VFEND. Patient was hospitalized. Patient died on 10/15/2006.Mylotarg Side Effects Report #5235843-8
Mylotarg side effect was reported by a Physician from JAPAN on Jan 31, 2007. Male patient, weighting 114.6 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anaemia, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, disease progression, disseminated intravascular coagulation, dyspnoea, fall
. Mylotarg dosage: unknown. During the same period patient was treated with LENDORMIN, ARTIST, TAKEPRON, MUCOSTA. Patient recovered.Mylotarg Side Effects Report #5238059-4
Mylotarg side effect was reported by a Physician from JAPAN on Feb 05, 2007. Male patient, weighting 130.1 lb, was diagnosed with acute myeloid leukaemia recurrent, hypertension, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: disseminated intravascular coagulation, fatigue, febrile neutropenia, hypotension, neutrophil count decreased, pneumonia
, pyrexia, thrombocytopenia. Mylotarg dosage: unknown. During the same period patient was treated with TENORMIN, NEORAL, ITRACONAZOLE, BAKTAR. Patient was hospitalized. Patient recovered.Mylotarg Side Effects Report #5245362-0
Mylotarg side effect was reported by a Physician from JAPAN on Feb 15, 2007. Female patient, weighting 132.3 lb, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: chills, disseminated intravascular coagulation, hypoxia, neutrophil count decreased, pyrexia. Mylotarg dosage: unknown. During the same period patient was treated with VANCOMYCIN HYDROCHLORIDE, VANCOMYCIN HYDROCHLORIDE, MEROPEN, OMEGACIN. Patient recovered.
Mylotarg Side Effects Report #5255383-X
Mylotarg side effect was reported by a Physician from JAPAN on Feb 21, 2007. Male patient, weighting 119.0 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: condition aggravated, disseminated intravascular coagulation, hypoxia, infection
, interstitial lung disease, tumour lysis syndrome. Mylotarg dosage: unknown. During the same period patient was treated with FIRSTCIN, DIOVAN, AMARYL, MELBIN, ORGARAN, FUNGUARD. Patient died on 06/23/2006.Mylotarg Side Effects Report #5264042-9
Mylotarg side effect was reported by a Physician from JAPAN on Mar 07, 2007. Male patient, weighting 149.9 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: disseminated intravascular coagulation, interstitial lung disease, neutrophil count decreased. Mylotarg dosage: unknown. During the same period patient was treated with OMEGACIN, NEUTROGIN, POLYMYXIN B SULPHATE, PARIET. Patient died on 04/24/2006.
Mylotarg Side Effects Report #5270234-5
Mylotarg side effect was reported by a Physician from JAPAN on Mar 12, 2007. Female patient, weighting 81.57 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blood uric acid increased, disseminated intravascular coagulation, hypoalbuminaemia, pneumonia
, renal failure. Mylotarg dosage: unknown. During the same period patient was treated with ISCOTIN, ISEPAMICIN SULPHATE, AMLODIN, STREPTOCOCCUS FAECALIS, FAMOTIDINE, CIPROFLOXACIN, BAKTAR. Patient was hospitalized. Patient recovered.Mylotarg Side Effects Report #5275036-1
Mylotarg side effect was reported by a Physician from JAPAN on Mar 15, 2007. Male patient, weighting 149.9 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis, sedation and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, anaemia, cellulitis
, disseminated intravascular coagulation, dysphagia, hepatic function abnormal, herpes simplex , hypoalbuminaemia, mouth haemorrhage. Mylotarg dosage: unknown. During the same period patient was treated with NOVANTRONE, POLYMYXIN B SULPHATE, FAMOTIDINE, BAKTAR, MIDAZOLAM, VFEND. Patient was hospitalized. Patient died on 10/15/2006.Mylotarg Side Effects Report #5280338-9
Mylotarg side effect was reported by a Physician from JAPAN on Mar 20, 2007. Female patient, weighting 132.3 lb, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: chills, condition aggravated, disseminated intravascular coagulation, hypoxia, neutrophil count decreased, pyrexia. Mylotarg dosage: unknown. During the same period patient was treated with VANCOMYCIN HYDROCHLORIDE, VANCOMYCIN HYDROCHLORIDE, MEROPEN, OMEGACIN. Patient recovered.
Mylotarg Side Effects Report #5283671-X
Mylotarg side effect was reported by a Physician from JAPAN on Mar 25, 2007. Male patient, weighting 149.9 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis, sedation and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, anaemia, cellulitis
, disseminated intravascular coagulation, dysphagia, hepatic function abnormal, herpes simplex , hypoalbuminaemia, mouth haemorrhage. Mylotarg dosage: unknown. During the same period patient was treated with NOVANTRONE, POLYMYXIN B SULPHATE, FAMOTIDINE, BAKTAR, MIDAZOLAM, VFEND. Patient was hospitalized. Patient died on 10/15/2006.Mylotarg Side Effects Report #5283739-8
Mylotarg side effect was reported by a Physician from JAPAN on Mar 23, 2007. Male patient, weighting 149.9 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis, emphysema and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: abdominal pain upper, anaemia, c-reactive protein increased, condition aggravated, disseminated intravascular coagulation, febrile neutropenia, peptic ulcer
, thrombocytopenia. Mylotarg dosage: unknown. During the same period patient was treated with MUCOSTA, BAKTAR, POLYMYXIN B SULPHATE, CLARITHROMYCIN, ZANTAC, DIFLUCAN. Patient was hospitalized. Patient recovered.Mylotarg Side Effects Report #5288523-7
Mylotarg side effect was reported by a Physician from JAPAN on Mar 29, 2007. Male patient, weighting 39.68 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anaemia, cardiac failure, disseminated intravascular coagulation, dyspnoea, hepatic function abnormal, hypoxia, pericardial effusion, pleural effusion, tumour lysis syndrome. Mylotarg dosage: unknown. During the same period patient was treated with NOVANTRONE, LENOGRASTIM, IDARUBICIN, FRAGMIN. Patient was hospitalized. Patient died on 03/29/2006.
Mylotarg Side Effects Report #5300795-9
Mylotarg side effect was reported by a Physician from JAPAN on Apr 12, 2007. Male patient, weighting 149.9 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis, sedation and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, anaemia, cellulitis
, disseminated intravascular coagulation, dysphagia, hepatic function abnormal, hypoalbuminaemia, mouth haemorrhage, neutrophil count decreased. Mylotarg dosage: unknown. During the same period patient was treated with NOVANTRONE, POLYMYXIN B SULPHATE, FAMOTIDINE, BAKTAR, MIDAZOLAM, VFEND. Patient was hospitalized. Patient died on 10/15/2006.Mylotarg Side Effects Report #5353493-X
Mylotarg side effect was reported by a Physician from JAPAN on May 31, 2007. Male patient, weighting 149.9 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis, emphysema and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: abdominal pain upper, anaemia, blast cell count increased, blood potassium increased, c-reactive protein increased, condition aggravated, disseminated intravascular coagulation, febrile neutropenia. Mylotarg dosage: unknown. During the same period patient was treated with MUCOSTA, BAKTAR, POLYMYXIN B SULPHATE, CLARITHROMYCIN, ZANTAC, DIFLUCAN. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #5384235-X
Mylotarg side effect was reported by a Physician from JAPAN on July 04, 2007. Female patient, weighting 85.98 lb, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: disseminated intravascular coagulation, febrile neutropenia, platelet count decreased, pleural effusion, weight increased. Mylotarg dosage: unknown. During the same period patient was treated with VANCOMYCIN, ZYVOX, VFEND, BAKTAR, DALACIN, ITRACONAZOLE. Patient recovered.
Mylotarg Side Effects Report #5402796-9
Mylotarg side effect was reported by a Physician from JAPAN on July 23, 2007. Female patient, weighting 35.27 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: disseminated intravascular coagulation, haemorrhagic diathesis, oedema. Mylotarg dosage: unknown. During the same period patient was treated with ACYCLOVIR, BAKTAR, PRODIF, PANSPORIN. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #5404331-8
Mylotarg side effect was reported by a Physician from JAPAN on July 26, 2007. Male patient, weighting 149.9 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: abdominal pain upper, anaemia, blast cell count increased, blood potassium increased, c-reactive protein increased, condition aggravated, disseminated intravascular coagulation, febrile neutropenia. Mylotarg dosage: unknown. During the same period patient was treated with BAKTAR, DIFLUCAN, POLYMYXIN B SULPHATE, ZANTAC, MUCOSTA. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #5475404-9
Mylotarg side effect was reported by a Physician from JAPAN on Sept 26, 2007. Female patient, weighting 125.7 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blood fibrinogen decreased, condition aggravated, disseminated intravascular coagulation, fibrin degradation products increased, hypokalaemia, platelet count decreased, white blood cell count decreased. Mylotarg dosage: unknown. During the same period patient was treated with RENIVACE, ADALAT, METHYCOBAL, POTASSIUM CHLORIDE, MUCOSOLVAN, LEVOFLOXACIN, DIFLUCAN. Patient recovered.
Mylotarg Side Effects Report #5531584-8
Mylotarg side effect was reported by a Physician from JAPAN on Nov 22, 2007. Female patient, weighting 114.6 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anaemia, cardiac failure congestive, depression
, disseminated intravascular coagulation, herpes zoster, herpes zoster infection neurological, neutrophil count decreased, retinal haemorrhage. Mylotarg dosage: unknown. During the same period patient was treated with NOVANTRONE, BACTRIM, MINOCYCLINE, DIFLUCAN, MEROPEN, FUNGUARD, AMIKACIN SULPHATE. Patient was hospitalized and became disabled. Patient recovered.Mylotarg Side Effects Report #5533308-7
Mylotarg side effect was reported by a Physician from JAPAN on Nov 29, 2007. Female patient, weighting 121.3 lb, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: disseminated intravascular coagulation, haematemesis, liver disorder, melaena. Mylotarg dosage: unknown. During the same period patient was treated with BLOPRESS, MEVALOTIN, ROCEPHIN, AMLODIN. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #5563271-4
Mylotarg side effect was reported by a Physician from JAPAN on Dec 12, 2007. Female patient, weighting 110.2 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: disseminated intravascular coagulation, pulmonary alveolar haemorrhage, sepsis
, venoocclusive liver disease. Mylotarg dosage: unknown. During the same period patient was treated with BIOFERMIN, ITRIZOLE, BAKTAR, GASTER, ASPARA K. Patient died on 11/18/2006.Mylotarg Side Effects Report #5564694-X
Mylotarg side effect was reported by a Physician from JAPAN on Dec 13, 2007. Male patient, weighting 145.5 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis, neutrophil count decreased and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: condition aggravated, disseminated intravascular coagulation, glucose tolerance impaired, haemolytic anaemia, hypokalaemia, left ventricular dysfunction, platelet count decreased, staphylococcal sepsis, white blood cell count decreased. Mylotarg dosage: unknown. During the same period patient was treated with FUNGUARD, CARBENIN, AMBISOME, CRAVIT, BAKTAR. Patient recovered.
Mylotarg Side Effects Report #5592209-9
Mylotarg side effect was reported by a Physician from JAPAN on Jan 07, 2008. Male patient, weighting 112.4 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anaemia, cerebral haemorrhage, disseminated intravascular coagulation, platelet count decreased, sepsis
. Mylotarg dosage: unknown. During the same period patient was treated with CYTARABINE, OMEPRAL, FUTHAN, ORGARAN, CRAVIT. Patient was hospitalized. Patient died on 10/25/2007.Mylotarg Side Effects Report #5592231-2
Mylotarg side effect was reported by a Physician from JAPAN on Jan 11, 2008. Female patient, weighting 35.27 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: disseminated intravascular coagulation, haemorrhagic diathesis, oedema. Mylotarg dosage: unknown. During the same period patient was treated with ACYCLOVIR, BAKTAR, PRODIF, PANSPORIN. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #5601602-7
Mylotarg side effect was reported by a Physician from JAPAN on Jan 15, 2008. Female patient, weighting 125.7 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anaemia, condition aggravated, disseminated intravascular coagulation, hypokalaemia, platelet count decreased, white blood cell count decreased. Mylotarg dosage: unknown. During the same period patient was treated with ENALAPRIL MALEATE, ADALAT, CYANOCOBALAMIN, POTASSIUM CHLORIDE, MUCOSOLVAN, CRAVIT, DIFLUCAN. Patient recovered.
Mylotarg Side Effects Report #5643265-0
Mylotarg side effect was reported by a Physician from JAPAN on Feb 22, 2008. Male patient, weighting 149.9 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: disseminated intravascular coagulation, interstitial lung disease, neutrophil count decreased. Mylotarg dosage: unknown. During the same period patient was treated with OMEGACIN, NEUTROGIN, POLYMYXIN B SULPHATE, PARIET. Patient was hospitalized. Patient died on 04/24/2006.
Mylotarg Side Effects Report #5683107-0
Mylotarg side effect was reported by a Physician from JAPAN on Mar 24, 2008. Male patient, weighting 112.4 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anaemia, cerebral haemorrhage, disseminated intravascular coagulation, febrile neutropenia, platelet count decreased, sepsis
. Mylotarg dosage: unknown. During the same period patient was treated with CYTARABINE, OMEPRAL, FUTHAN, ORGARAN, CRAVIT. Patient was hospitalized. Patient died on 10/25/2007.Mylotarg Side Effects Report #5834927-0
Mylotarg side effect was reported by a Physician from JAPAN on July 28, 2008. Female patient, weighting 114.6 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anaemia, cardiac failure congestive, depression
, disseminated intravascular coagulation, herpes zoster, neutrophil count decreased, post herpetic neuralgia, retinal haemorrhage. Mylotarg dosage: unknown. During the same period patient was treated with NOVANTRONE, COTRIM, MINOCYCLINE, DIFLUCAN, MEROPEN, FUNGUARD, AMIKACIN SULPHATE. Patient was hospitalized and became disabled. Patient recovered.Mylotarg Side Effects Report #6104530-6
Mylotarg side effect was reported by a Physician from JAPAN on Feb 24, 2009. Male patient, weighting 145.5 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis, neutrophil count decreased and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: condition aggravated, disseminated intravascular coagulation, glucose tolerance impaired, haemolytic anaemia, hypokalaemia, left ventricular dysfunction, platelet count decreased, staphylococcal sepsis, white blood cell count decreased. Mylotarg dosage: unknown. During the same period patient was treated with FUNGUARD, CARBENIN, AMBISOME, CRAVIT, BAKTAR. Patient recovered.
Mylotarg Side Effects Report #6137719-0
Mylotarg side effect was reported by a Physician from JAPAN on Mar 26, 2009. Female patient, weighting 114.6 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anaemia, blood lactate dehydrogenase increased, cardiac failure congestive, depression
, disseminated intravascular coagulation, herpes zoster, neutrophil count decreased, post herpetic neuralgia, retinal haemorrhage. Mylotarg dosage: unknown. During the same period patient was treated with NOVANTRONE, BAKTAR, MINOCYCLINE, DIFLUCAN, MEROPEN, FUNGUARD, AMIKACIN SULPHATE. Patient was hospitalized and became disabled. Patient recovered.Mylotarg Side Effects Report #4992449-3
Mylotarg side effect was reported by a Health Professional from JAPAN on Apr 20, 2006. Female patient was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: abdominal distension, anaemia, blood lactate dehydrogenase, bone pain, chills, diarrhoea, disseminated intravascular coagulation, hypoalbuminaemia, hypokalaemia. Mylotarg dosage: unknown. During the same period patient was treated with FUNGIZONE, POLYMYXIN B SULPHATE, ALLOID, BACTRIM, BIOFERMIN R, TIENAM. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #5010988-6
Mylotarg side effect was reported by a Health Professional from JAPAN on May 15, 2006. Female patient was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: abdominal distension, acute myeloid leukaemia recurrent, anaemia, blood lactate dehydrogenase increased, bone pain, chills, diarrhoea, disseminated intravascular coagulation, hypoalbuminaemia. Mylotarg dosage: unknown. During the same period patient was treated with FUNGIZONE, POLYMYXIN B SULPHATE, ALLOID, BACTRIM, BIOFERMIN R, TIENAM, DAUNORUBICIN HYDROCHLORIDE. Patient was hospitalized. Patient died.
Mylotarg Side Effects Report #5506771-5
Mylotarg side effect was reported by a Physician from JAPAN on Nov 01, 2007. Female patient, 86 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: disseminated intravascular coagulation, infection
. Mylotarg dosage: unknown. Patient died on 08/26/2007.Mylotarg Side Effects Report #4620666-0
Mylotarg side effect was reported by a Consumer or non-health professional from on Mar 17, 2005. Female patient, 74 years of age, weighting 156.5 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: arrhythmia
, disseminated intravascular coagulation, hypotension, respiratory distress. Mylotarg dosage: 15 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with LASIX, PROTONIX, ALLOPURINOL, TYLENOL, HALDOL, ARICEPT, CELEXA, ZOSYN. Patient was hospitalized. Patient died on 03/03/2004.Mylotarg Side Effects Report #4947093-0
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 08, 2006. Female patient, 74 years of age, weighting 156.5 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: arrhythmia
, condition aggravated, disseminated intravascular coagulation, hypotension, infusion related reaction, respiratory distress, white blood cell count increased. Mylotarg dosage: 15 MG 1X PER 1 DAY; INTRAVENOUS. During the same period patient was treated with LASIX, PROTONIX, ALLOPURINOL, ACETAMINOPHEN, HALDOL SOLUTAB, ARICEPT, CELEXA, ZOSYN. Patient was hospitalized. Patient died on 03/03/2004.Mylotarg Side Effects Report #5150679-4
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Oct 30, 2006. Male patient, 73 years of age, was diagnosed with acute myeloid leukaemia, leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: disease progression, disseminated intravascular coagulation, hypoxia, infection
, interstitial lung disease, weight increased, white blood cell count decreased, white blood cell count increased. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY INTRAVENOUS DRIP. During the same period patient was treated with ORGARAN, FIRSTCIN, FUNGUARD, AMARYL, METFORMIN HYDROCHLORIDE, DIOVAN. Patient died.Mylotarg Side Effects Report #4688391-8
Mylotarg side effect was reported by a Health Professional from on June 10, 2005. Female patient, 73 years of age, weighting 148.0 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: disseminated intravascular coagulation. Mylotarg dosage: 10.6MG IV DAY 1. During the same period patient was treated with CYTOSAR. Patient died on 12/27/2004.
Mylotarg Side Effects Report #4869970-1
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 18, 2002. Female patient, 71 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: cerebral haemorrhage, coagulopathy, confusional state, dialysis
, disseminated intravascular coagulation, haemoptysis, hepatic enzyme increased, melaena, multi-organ failure. Mylotarg dosage: unknown. During the same period patient was treated with CYTARABINE. Patient was hospitalized. Patient died on 12/30/2001.Mylotarg Side Effects Report #4990373-3
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Apr 14, 2006. Male patient, child 7 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anaemia, chills, disseminated intravascular coagulation, dyspnoea, hepatic function abnormal, hypoxia, neutrophil count decreased, pericardial effusion, platelet count decreased. Mylotarg dosage: 6 MG/M^2 1X PER 1 DAY, INTRAVENOUS DRIP. During the same period patient was treated with CYTARABINE, NOVANTRONE, NEUTROGIN, IDARUBICIN, FRAGMIN, FUTHAN, STRONG NEO MINOPHAGEN C. Patient recovered.
Mylotarg Side Effects Report #4996486-4
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Apr 25, 2006. Female patient, 69 years of age, was diagnosed with acute myeloid leukaemia, herpes zoster and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anaemia, disease progression, disseminated intravascular coagulation, febrile neutropenia, herpes zoster, hypocalcaemia, hypokalaemia, renal impairment. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY INTRAVENOUS DRIP. During the same period patient was treated with ACICLOVIR, ETOPOSIDE, MEROPEN, LEVOFLOXACIN, DIFLUCAN, FAMOTIDINE, PREDNISOLONE, MAGNESIUM OXIDE. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #5032005-4
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on June 08, 2006. Female patient, 69 years of age, was diagnosed with acute myeloid leukaemia, herpes zoster and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, anaemia, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, disease progression, disseminated intravascular coagulation, febrile neutropenia, hepatic function abnormal. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY, INTRAVENOUS DRIP. During the same period patient was treated with ACYCLOVIR, ETOPOSIDE, MEROPEN, LEVOFLOXACIN, DIFLUCAN, FAMOTIDINE, PREDNISOLONE, MAGNESIUM OXIDE. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #4953997-5
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Mar 09, 2006. Male patient, 68 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blast cell count increased, blood pressure increased, disseminated intravascular coagulation, dizziness
, febrile neutropenia, glucose urine, hepatic failure, hyperhidrosis, infusion related reaction. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY INTRAVENOUS DRIP. During the same period patient was treated with DAUNORUBICIN HYDROCHLORIDE, INSULIN, BASEN, BUFFERIN, RABEPRAZOLE, GLYBURIDE, EVIPROSTAT, GLUCOBAY. Patient died.Mylotarg Side Effects Report #4961735-5
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Mar 20, 2006. Male patient, 68 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: disseminated intravascular coagulation, fatigue, febrile neutropenia, hypotension, thrombocytopenia. Mylotarg dosage: unknown. During the same period patient was treated with ITRACONAZOLE, SULFAMETHOXAZOLE, NEORAL, TENORMIN. Patient recovered.
Mylotarg Side Effects Report #5223121-2
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Jan 11, 2007. Female patient, 66 years of age, was diagnosed with acute myeloid leukaemia, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anorexia, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, disseminated intravascular coagulation, dysgeusia, fatigue, gamma-glutamyltransferase increased, herpes simplex
. Mylotarg dosage: 6 MG/M^2 1X PER 1 DAY INTRAVENOUS DRIP. During the same period patient was treated with FAMOTIDINE, ISEPACIN, CLINDAMYCIN PHOSPHATE, NEUPOGEN, BAKTAR, MEROPEN. Patient was hospitalized. Patient recovered.Mylotarg Side Effects Report #5090630-9
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 10, 2006. Female patient, 66 years of age, weighting 196.2 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: colitis, disseminated intravascular coagulation, febrile neutropenia, hepatic steatosis, lethargy, pleural effusion, renal failure, sepsis
, venoocclusive liver disease. Mylotarg dosage: 17.73 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with CYTARABINE. Patient was hospitalized. Patient died on 03/01/2004.Mylotarg Side Effects Report #5103248-6
Mylotarg side effect was reported by a Health Professional from JAPAN on Aug 28, 2006. Female patient, 66 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anorexia, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, disseminated intravascular coagulation, dysgeusia, fatigue, gamma-glutamyltransferase increased, herpes simplex
. Mylotarg dosage: unknown. During the same period patient was treated with FAMOTIDINE, SULFAMETHOXAZOLE, VFEND, MEROPEN, ISEPACIN, CLINDAMYCIN PHOSPHATE. Patient was hospitalized. Patient recovered.Mylotarg Side Effects Report #4998572-1
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Apr 26, 2006. Male patient, 66 years of age, was diagnosed with acute myeloid leukaemia, sinusitis
and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, blood lactate dehydrogenase increased, c-reactive protein increased, disseminated intravascular coagulation, fibrin d dimer increased, gamma-glutamyltransferase increased, haemoglobin decreased, hypoalbuminaemia, neutrophil count decreased. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY INTRAVENOUS DRIP. During the same period patient was treated with CARBENIN, CRAVIT, VANCOMYCIN HYDROCHLORIDE, VFEND, ZANTAC, MUCOSTA, URSO. Patient was hospitalized. Patient recovered.Mylotarg Side Effects Report #5373416-7
Mylotarg side effect was reported by a Physician from JAPAN on June 25, 2007. Female patient, 63 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: disseminated intravascular coagulation, haematemesis, hepatic function abnormal, melaena. Mylotarg dosage: unknown. Patient recovered.
Mylotarg Side Effects Report #4869686-1
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Dec 20, 2005. Male patient, 63 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acidosis, acute myeloid leukaemia, alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, disseminated intravascular coagulation, febrile neutropenia, gamma-glutamyltransferase increased. Mylotarg dosage: 9 MG/M 2 1X PER 1 DAY. Patient died.
Mylotarg Side Effects Report #5049337-6
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on June 27, 2006. Male patient, 56 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: atelectasis, bradycardia, cerebral haemorrhage, cerebrovascular accident, disseminated intravascular coagulation, hypertension, ischaemic stroke, prostate cancer metastatic, pulmonary oedema. Mylotarg dosage: 18.9 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with AMPICILLIN, LEVOFLOXACIN, DEXAMETHASONE, CEFEPIME, TRETINOIN, VANCOMYCIN, ALLOPURINOL. Patient recovered.
Mylotarg Side Effects Report #4771429-7
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 01, 2005. Male patient, 56 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: atelectasis, blood uric acid increased, bradycardia, cerebral artery occlusion, cerebral haemorrhage, convulsion, culture urine positive, disseminated intravascular coagulation, enterococcal infection. Mylotarg dosage: 18.9 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with AMPICILLIN, LEVOFLOXACIN, DEXAMETHASONE, CEFEPIME, TRETINOIN, VANCOMYCIN, ALLOPURINOL. Patient recovered.
Mylotarg Side Effects Report #5023602-0
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on May 25, 2006. Female patient, 55 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blood creatinine increased, condition aggravated, disease progression, disseminated intravascular coagulation, pyrexia, venoocclusive liver disease. Mylotarg dosage: unknown. During the same period patient was treated with CARBENIN, MAXIPIME, AMIKACIN SULPHATE, PRODIF, ANTITHROMBIN III, FRAGMIN. Patient recovered.
Mylotarg Side Effects Report #5084007-X
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Aug 02, 2006. Female patient, 54 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anaphylactic shock, condition aggravated, disseminated intravascular coagulation, renal failure. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY INTRAVENOUS DRIP. During the same period patient was treated with MAXIPIME, MINOCYCLINE HYDROCHLORIDE, FUTHAN. Patient recovered.
Mylotarg Side Effects Report #5624965-5
Mylotarg side effect was reported by a Physician from JAPAN on Feb 07, 2008. Female patient, 50 years of age, weighting 90.39 lb, was diagnosed with acute myeloid leukaemia, prophylaxis, pneumonia
and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anaemia, blood lactate dehydrogenase increased, disseminated intravascular coagulation, hypokalaemia, neutrophil count decreased, platelet count decreased, pneumonia , sepsis , tumour lysis syndrome. Mylotarg dosage: unknown. During the same period patient was treated with REBAMIPIDE, VFEND, MEROPEN, ARBEKACIN, RANITIDINE HYDROCHLORIDE. Patient died on 03/07/2007.Mylotarg Side Effects Report #5683019-2
Mylotarg side effect was reported by a Physician from JAPAN on Mar 24, 2008. Female patient, 50 years of age, weighting 90.39 lb, was diagnosed with acute myeloid leukaemia, prophylaxis, pneumonia
and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anaemia, blood lactate dehydrogenase increased, disseminated intravascular coagulation, hypokalaemia, neutrophil count decreased, platelet count decreased, pneumonia , sepsis , tumour lysis syndrome. Mylotarg dosage: unknown. During the same period patient was treated with REBAMIPIDE, VFEND, MEROPEN, ARBEKACIN, RANITIDINE HYDROCHLORIDE. Patient died on 03/07/2007.Mylotarg Side Effects Report #4949582-1
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 07, 2006. Female patient, 50 years of age, weighting 129.0 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: ascites, atelectasis, blood creatinine increased, blood urea increased, disease progression, disseminated intravascular coagulation, haemoglobin decreased, hypoalbuminaemia, hypotension. Mylotarg dosage: 15 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with BACTRIM DS, ADVAIR DISKUS, ALPHAGAN, ATROVENT, PROVENTIL, PROTONIX, AMBIEN, VITAMINS. Patient was hospitalized. Patient died on 10/02/2003.
Mylotarg Side Effects Report #5150664-2
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Oct 27, 2006. Male patient, 46 years of age, was diagnosed with acute myeloid leukaemia, leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, anaemia, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, c-reactive protein increased, disseminated intravascular coagulation, febrile neutropenia, fibrin degradation products increased. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY INTRAVENOUS DRIP. During the same period patient was treated with CYTARABINE, FRAGMIN, KYTRIL, NORVASC, URSO. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #4958939-4
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 15, 2006. Female patient, 28 years of age, weighting 151.9 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: bacteria blood identified, bacterial infection
, cholecystitis, culture positive, disseminated intravascular coagulation, enterococcal infection, haematocrit decreased, haemoglobin decreased, klebsiella infection. Mylotarg dosage: A SINGLE 6 MG/M^2 DOSE, INTRAVENOUS. During the same period patient was treated with CYTARABINE, DAUNOMYCIN. Patient was hospitalized. Patient recovered.Mylotarg Side Effects Report #4908980-2
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Dec 01, 2003. Female patient, 19 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: abdominal pain upper, anorexia, aspartate aminotransferase increased, blood bilirubin increased, conjunctival haemorrhage, disseminated intravascular coagulation, dyspnoea, febrile neutropenia, fluid overload. Mylotarg dosage: 18.6 MG ONE TIME PER ONE DOSE, INTRAVENOUS. During the same period patient was treated with CYTARABINE, DAUNORUBICIN. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #5238442-7
Mylotarg side effect was reported by a Physician from JAPAN on Feb 06, 2007. Female patient, weighting 108.0 lb, was diagnosed with acute myeloid leukaemia, prophylaxis, pneumonia
and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: disseminated intravascular coagulation, febrile neutropenia, liver disorder. Mylotarg dosage: unknown. During the same period patient was treated with PREDONINE, TAKEPRON, FUNGIZONE, BAKTAR, PROVIODINE, PENTCILLIN, PRODIF. Patient recovered.Mylotarg Side Effects Report #5244323-5
Mylotarg side effect was reported by a Physician from JAPAN on Feb 15, 2007. Male patient, weighting 121.3 lb, was diagnosed with acute myeloid leukaemia, constipation
, arrhythmia , prophylaxis, tumour associated fever, haemorrhagic diathesis, benign prostatic hyperplasia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: disseminated intravascular coagulation, gastrointestinal haemorrhage, hepatic function abnormal, renal failure, sepsis . Mylotarg dosage: unknown. During the same period patient was treated with MAGNESIUM OXIDE, SUNRYTHM, SELBEX, NAPROXEN, ADONA, HARNAL, FLUCONAZOLE. Patient was hospitalized. Patient died on 02/01/2007.Mylotarg Side Effects Report #5284200-7
Mylotarg side effect was reported by a Physician from JAPAN on Mar 22, 2007. Female patient, weighting 105.8 lb, was diagnosed with acute myeloid leukaemia, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, disseminated intravascular coagulation, gamma-glutamyltransferase increased, herpes simplex
, pyrexia, tumour lysis syndrome, white blood cell count decreased. Mylotarg dosage: unknown. During the same period patient was treated with BAKTAR, VFEND, TARGOCID, ISEPACIN, DALACIN, GASTER. Patient was hospitalized. Patient recovered.Mylotarg Side Effects Report #5289610-X
Mylotarg side effect was reported by a Physician from JAPAN on Mar 29, 2007. Male patient, weighting 132.3 lb, was diagnosed with acute myeloid leukaemia, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blood urea increased, cerebral haemorrhage, disseminated intravascular coagulation, febrile neutropenia, hypernatraemia, pneumonia
, sepsis . Mylotarg dosage: unknown. During the same period patient was treated with MAGNESIUM OXIDE, ALTAT, SELBEX, GLUCOSEECTION, VITAMEDIN, SOLDEM, STRONG NEO MINOPHAGEN C. Patient was hospitalized. Patient died on 02/27/2007.Mylotarg Side Effects Report #5302162-0
Mylotarg side effect was reported by a Physician from JAPAN on Apr 12, 2007. Male patient, weighting 121.3 lb, was diagnosed with acute myeloid leukaemia, constipation
, arrhythmia , prophylaxis, benign prostatic hyperplasia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: disseminated intravascular coagulation, gastrointestinal haemorrhage, haemorrhagic diathesis, hepatic function abnormal, renal failure, sepsis , septic shock, subdural haemorrhage. Mylotarg dosage: unknown. During the same period patient was treated with MAGNESIUM OXIDE, SUNRYTHM, SELBEX, FUNGUARD, BAKTAR, HARNAL, FLUCONAZOLE. Patient was hospitalized. Patient died on 02/01/2007.Mylotarg Side Effects Report #5384163-X
Mylotarg side effect was reported by a Physician from JAPAN on July 02, 2007. Male patient, weighting 121.3 lb, was diagnosed with acute myeloid leukaemia, constipation
, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: disseminated intravascular coagulation, gastrointestinal haemorrhage, haemorrhagic diathesis, hepatic function abnormal, renal failure, sepsis , septic shock, subdural haemorrhage. Mylotarg dosage: unknown. During the same period patient was treated with MAGNESIUM OXIDE, SELBEX, FUNGUARD, BAKTAR, FLUCONAZOLE, POLYMYXIN B SULPHATE. Patient was hospitalized. Patient died on 02/01/2007.Mylotarg Side Effects Report #5395435-7
Mylotarg side effect was reported by a Physician from JAPAN on July 17, 2007. Male patient, weighting 132.3 lb, was diagnosed with acute myeloid leukaemia, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blood urea increased, cerebral haemorrhage, condition aggravated, disseminated intravascular coagulation, febrile neutropenia, hypernatraemia, pneumonia
, renal impairment. Mylotarg dosage: unknown. During the same period patient was treated with MAGNESIUM OXIDE, ROXATIDINE ACETATE, GLUCOSEECTION, DIFLUCAN, VITAMEDIN, SOLDEM, STRONG NEO MINOPHAGEN C. Patient was hospitalized. Patient died on 02/23/2007.Mylotarg Side Effects Report #5419702-3
Mylotarg side effect was reported by a Physician from JAPAN on Aug 10, 2007. Male patient, weighting 138.9 lb, was diagnosed with acute myeloid leukaemia, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: apnoeic attack, bacterial infection
, disseminated intravascular coagulation, gastrointestinal haemorrhage, hypokalaemia, pancytopenia, pulmonary haemorrhage, tetany. Mylotarg dosage: unknown. During the same period patient was treated with SUCRALFATE, POLYMYXIN B SULPHATE, BAKTAR, FUNGIZONE. Patient recovered.Mylotarg Side Effects Report #5451515-9
Mylotarg side effect was reported by a Physician from JAPAN on Sept 04, 2007. Male patient, weighting 132.3 lb, was diagnosed with acute myeloid leukaemia, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blood urea increased, cerebral haemorrhage, condition aggravated, disseminated intravascular coagulation, febrile neutropenia, hypernatraemia, pneumonia
, renal impairment. Mylotarg dosage: unknown. During the same period patient was treated with MAGNESIUM OXIDE, ROXATIDINE ACETATE, GLUCOSEECTION, DIFLUCAN, VITAMEDIN, SOLDEM, STRONG NEO MINOPHAGEN C. Patient was hospitalized. Patient died on 02/23/2007.Mylotarg Side Effects Report #5499630-8
Mylotarg side effect was reported by a Physician from JAPAN on Oct 22, 2007. Female patient, weighting 112.4 lb, was diagnosed with acute myeloid leukaemia, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: disseminated intravascular coagulation, febrile neutropenia, haemoglobin decreased, neutrophil count decreased, platelet count decreased, pneumonia
, pulmonary haemorrhage, white blood cell count decreased. Mylotarg dosage: unknown. During the same period patient was treated with LASIX, BAKTAR, ALTAT, CIBENOL, ZOLPIDEM TARTRATE, ENTERONON, MAGNESIUM OXIDE. Patient died on 08/21/2007.Mylotarg Side Effects Report #5534483-0
Mylotarg side effect was reported by a Physician from JAPAN on Nov 28, 2007. Female patient, weighting 112.4 lb, was diagnosed with acute myeloid leukaemia, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anaemia, disseminated intravascular coagulation, febrile neutropenia, neutrophil count decreased, platelet count decreased, pneumonia
, pseudomembranous colitis, pulmonary haemorrhage, white blood cell count decreased. Mylotarg dosage: unknown. During the same period patient was treated with LASIX, BACTRIM, ALTAT, CIBENOL, ZOLPIDEM TARTRATE, ENTERONON, MAGNESIUM OXIDE. Patient died on 08/21/2007.Mylotarg Side Effects Report #5557856-9
Mylotarg side effect was reported by a Physician from JAPAN on Dec 04, 2007. Male patient, weighting 99.21 lb, was diagnosed with acute myeloid leukaemia, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: disseminated intravascular coagulation, liver disorder, neutrophil count decreased, sepsis
, septic shock. Mylotarg dosage: unknown. During the same period patient was treated with HARNAL, ISCOTIN, PYDOXAL, CIPROFLOXACIN, DIFLUCAN, VFEND, FIRSTCIN, RABEPRAZOLE. Patient died on 02/01/2007.Mylotarg Side Effects Report #5570764-2
Mylotarg side effect was reported by a Physician from JAPAN on Dec 13, 2007. Female patient, weighting 105.8 lb, was diagnosed with acute myeloid leukaemia, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, disseminated intravascular coagulation, gamma-glutamyltransferase increased, oral herpes, pyrexia, sepsis
, tumour lysis syndrome. Mylotarg dosage: unknown. During the same period patient was treated with BAKTAR, VFEND, MEROPEN, ACLARUBICIN, DALACIN. Patient was hospitalized. Patient recovered.Mylotarg Side Effects Report #5634876-7
Mylotarg side effect was reported by a Physician from JAPAN on Feb 19, 2008. Female patient, weighting 112.4 lb, was diagnosed with acute myeloid leukaemia, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anaemia, disseminated intravascular coagulation, febrile neutropenia, neutrophil count decreased, platelet count decreased, pneumonia
, pseudomembranous colitis, pulmonary haemorrhage, white blood cell count decreased. Mylotarg dosage: unknown. During the same period patient was treated with LASIX, BAKTAR, ALTAT, CIBENOL, ZOLPIDEM, ENTERONON, MAGNESIUM OXIDE. Patient died on 08/21/2007.Mylotarg Side Effects Report #5987177-1
Mylotarg side effect was reported by a Physician from JAPAN on Nov 28, 2008. Female patient, weighting 108.0 lb, was diagnosed with acute myeloid leukaemia, prophylaxis, pneumonia
and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: disseminated intravascular coagulation, febrile neutropenia, liver disorder, pneumonia , shock. Mylotarg dosage: unknown. During the same period patient was treated with PREDONINE, TAKEPRON, FUNGIZONE, COTRIM, PROVIODINE, PENTCILLIN, PRODIF. Patient recovered.Mylotarg Side Effects Report #5087317-5
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Aug 08, 2006. Male patient, 18 years of age, was diagnosed with acute leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, disseminated intravascular coagulation, hyperbilirubinaemia, infusion related reaction, platelet count decreased, prothrombin time prolonged, renal failure acute. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY INTRAVENOUS DRIP. During the same period patient was treated with CYTARABINE, ACYCLOVIR, MEROPEN, VFEND, TARGOCID, CIPROXAN, GANCICLOVIR, URSO. Patient recovered.
Mylotarg Side Effects Report #5162193-0
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Nov 13, 2006. Male patient, 18 years of age, was diagnosed with acute leukaemia, prophylaxis, sepsis
, graft versus host disease and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: chronic graft versus host disease, condition aggravated, disseminated intravascular coagulation, hyperbilirubinaemia, oxygen saturation decreased, renal failure acute, sepsis . Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY INTRAVENOUS DRIP. During the same period patient was treated with ACYCLOVIR, CYTARABINE, FAMOTIDINE, MEROPEN, PROGRAF, TARGOCID. Patient recovered.Mylotarg Side Effects Report #5287665-X
Mylotarg side effect was reported by a Physician from JAPAN on Mar 27, 2007. Male patient, weighting 121.3 lb, was diagnosed with acute leukaemia, prophylaxis, sepsis
, cytomegalovirus viraemia, cholestasis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blood pressure decreased, chronic graft versus host disease, condition aggravated, disseminated intravascular coagulation, hyperbilirubinaemia, oxygen saturation decreased, platelet count decreased, renal failure acute, sepsis . Mylotarg dosage: unknown. During the same period patient was treated with ACYCLOVIR, MEROPEN, VFEND, TARGOCID, CIPROFLOXACIN, GANCICLOVIR. Patient recovered.